SCHEMBL73467

SCHEMBL73467

OC1Cc2ccccc2C1

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 3/20 0.46
ANPEP P15144 1/20 0.45
PLAU P00749 1/20 0.42
SLC18A3 Q16572 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29728630 1.00 IDO1 (0.46) IDO1ANPEPPLAUSLC18A3
Ammonia Solution, Strong SCHEMBL7301670 0.97 IDO1 (0.44) IDO1ANPEPPLAU
Hydrochloric Acid SCHEMBL4151874 0.97 ANPEP (0.48) IDO1ANPEPPLAU
Methyl Alcohol SCHEMBL28162178 0.94 IDO1 (0.42) IDO1ANPEPPLAU
Dioxane SCHEMBL3940644 0.85 ANPEP (0.41) IDO1ANPEPPLAU
SCHEMBL6951241 0.82 ANPEP (0.57) ANPEPPLAU
SCHEMBL291460 0.82 ANPEP (0.57) ANPEPPLAU
SCHEMBL13998125 0.82 ANPEP (0.57) ANPEPPLAU
SCHEMBL2943529 0.82 ANPEP (0.57) ANPEPPLAU
SCHEMBL20063792 0.81 ANPEP (0.56) IDO1ANPEPPLAUSLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534442-B2 Benzisoxazole derivative Sumitomo Pharma Co., Ltd. (JP) 2026-01-27 US claimed
US-12129429-B1 Method for paraffin inhibiting Skaiblue Fund LLC 2024-10-29 US claimed
US-20230202991-A1 BENZISOXAZOLE DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-06-29 US claimed
EP-4180090-A1 BENZISOXAZOLE DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-05-17 EP claimed
EP-4132918-A1 NEW ANTI-MALARIAL AGENTS University Of Kentucky Research Foundation (US) 2023-02-15 EP claimed
CN-110183330-B Preparation method of 5, 6-diethyl-2, 3-dihydro-1H-indene-2-amine hydrochloride 安徽华邦药业有限公司 2022-05-27 CN claimed
EP-3621619-A1 COMPOUNDS AND METHODS FOR TREATMENT OF VISCERAL PAIN Arena Pharmaceuticals, Inc. (US) 2020-03-18 EP claimed
CN-110183330-A A kind of preparation method of 5,6- diethyl -2,3- dihydro -1H- indenes -2- amine hydrochlorate 南京焕然生物科技有限公司 2019-08-30 CN claimed
US-10256408-B2 Composition and method for preparation of organic electronic devices MERCK PATENT GMBH (DE) 2019-04-09 US claimed
US-10227305-B2 Process for preparing indacaterol and salts thereof REDDY, G. Pratap (IN) 2019-03-12 US claimed
EP-0743573-A2 Method for obtaining image contrast migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
EP-0743574-A2 Migration imaging members XEROX CORPORATION (US) 1996-11-20 EP claimed
US-5563014-A SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT XEROX CORPORATION (US) 1996-10-08 US claimed
US-5514505-A SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE XEROX CORPORATION (US) 1996-05-07 US claimed
EP-0674232-A2 Recording sheets XEROX CORPORATION (US) 1995-09-27 EP claimed
US-5451466-A Electrophotographic use, reduced heat and energy required for toner fusion, styrene copolymer, indan or derivative XEROX CORPORATION (US) 1995-09-19 US claimed
EP-0357742-A1 NEW PYRETHRINOID ESTERS CARRYING AN INDANYL RING, PREPARATION METHOD AND APPLICATION AS PESTICIDES. ROUSSEL UCLAF (FR) 1990-03-14 EP claimed
WO-1989008096-A1 NEW PYRETHRINOID ESTERS CARRYING AN INDANYL RING, PREPARATION METHOD AND APPLICATION AS PESTICIDES ROUSSEL-UCLAF (FR) 1989-09-08 WO claimed
CN-87103809-A The method for making of naphthane and indan derivative 1987-12-02 CN claimed
EP-0069761-B1 (+)-4-SUBSTITUTED-2-INDANOLS AND INSECTICIDAL ESTER DERIVATIVES FMC Corporation (US) 1985-08-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10227305-B2 Process for preparing indacaterol and salts thereof CYP4A11, HSD17B7, CYP17A1 IDO1 230/4885ANPEP 1424/4885PLAU 4118/4885
US-20230202991-A1 BENZISOXAZOLE DERIVATIVE HDAC3, GABRA5, HDAC2 IDO1 1217/4885ANPEP 4435/4885PLAU 3917/4885
US-12534442-B2 Benzisoxazole derivative GABRA6, SLC6A1, GABRA1 IDO1 1316/4885ANPEP 3778/4885PLAU 4358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.